Cholesterol is Not the Cause of Heart Disease

The BIG MYTH Behind Heart Disease & What ACTUALLY CAUSES It!

Dr. Elizabeth Boham & Mark Hyman

Discover why cholesterol is just one piece of the heart disease puzzle and how focusing on root causes like inflammation, insulin resistance, and lifestyle can dramatically lower your real cardiovascular risk.

Video overview

In this conversation, Dr. Mark Hyman and Dr. Elizabeth Boham explain that cholesterol is only one of many factors driving heart disease, and that standard cholesterol tests often miss the real risks hidden in particle size, particle number, and metabolic health. They show how insulin resistance, belly fat, inflammation, oxidative stress, toxins, and the microbiome interact to damage arteries, and they walk through real patient cases where targeted lifestyle changes reversed dangerous lipid patterns and reduced the need for statin drugs.

Summary

This episode of The Doctor’s Farmacy features Dr. Mark Hyman interviewing functional medicine physician and nutritionist Dr. Elizabeth Boham about what cholesterol really means for heart disease risk. They emphasize that cholesterol is “one factor, one piece of the puzzle” and that many people with “high” cholesterol may not need medication, while others with “normal” cholesterol can still be at high risk.
They explain why a traditional lipid panel (total cholesterol, LDL, HDL, triglycerides) is outdated and incomplete, because it measures only the “weight” of cholesterol but not the number or size of lipoprotein particles that actually injure arteries. Using analogies like “dirt and dump trucks” and “golf balls versus beach balls,” they show why small, dense LDL particles are far more dangerous than large, light “fluffy” ones.
Drs. Hyman and Boham highlight how insulin resistance and metabolic syndrome (high waist circumference, low HDL, high triglycerides, elevated insulin and blood sugar) drive small, dense LDL, high triglycerides, and low HDL, greatly increasing heart attack risk even when total cholesterol looks “good.” They note that around half of Americans have prediabetes or type 2 diabetes, and that about two‑thirds of people who show up in the ER with a heart attack have prediabetes or diabetes, most of it undiagnosed.
The discussion goes deep into inflammation and oxidative stress as the “special ingredients” that turn cholesterol into a true problem, with visceral belly fat acting as an inflammatory organ releasing “adipocytokines” that promote oxidative damage to LDL. Oxidized (“rancid”) LDL is much more likely to penetrate arteries, form plaque, rupture, and trigger sudden heart attacks, even when arteries were only moderately narrowed before.
They describe more advanced testing that goes beyond standard cholesterol numbers, including NMR lipoprotein profiles (LabCorp), Cardio IQ (Quest), oxidized LDL, fasting insulin, insulin resistance scores, homocysteine, lipoprotein(a), inflammatory markers, oxidative stress markers, and even microbiome and toxin assessments. They also discuss imaging such as coronary calcium scores and carotid ultrasounds to directly measure plaque burden.
The video addresses when statin drugs are appropriate, stressing that statins have benefits and risks and should be used for the right patient based on family history, plaque evidence, and overall risk rather than cholesterol alone. They point out that statins may work partly due to anti‑inflammatory effects, and that there are often better ways to reduce inflammation through diet, exercise, weight loss, sleep, and toxin reduction.
Through detailed case studies, they show how low‑glycemic, low‑sugar diets, increased omega‑3 intake, and lifestyle changes can rapidly shift people from dangerous “pattern B” (small, dense LDL) to safer “pattern A” (large, fluffy LDL), normalize triglycerides and HDL, and even allow some patients to safely discontinue statins under medical supervision. They also emphasize personalization: the same high‑fat or ketogenic diet can dramatically improve one person’s lipids while worsening another’s, and future genetic testing may help match diet type to each individual’s biology.

Transcript Summary

Key ideas from the transcript

Cholesterol is one factor in cardiovascular risk, not the whole story; many people with elevated cholesterol do not need drugs, and cholesterol results must be interpreted in context.
Standard lipid panels miss crucial information, because they measure total cholesterol and LDL/HDL “weight” but not particle number and size, which are more predictive of risk.
Small, dense LDL particles (the “golf balls” or many tiny dump trucks) are more likely to penetrate the artery wall, oxidize, and cause plaque and heart attacks than large, buoyant particles.
Insulin resistance and metabolic syndrome (belly fat, low HDL, high triglycerides, high insulin) are major drivers of dangerous lipid patterns and heart disease, affecting a majority of adults.
Visceral belly fat is metabolically active tissue that secretes inflammatory cytokines, fueling oxidative stress, oxidized LDL, and plaque instability that can rupture suddenly.
Inflammation and oxidative stress are central to heart disease; markers such as oxidized LDL, inflammatory markers, and oxidative stress markers can reveal risk that standard tests miss.
Advanced testing (NMR, Cardio IQ, insulin resistance scores, coronary calcium scans, carotid ultrasound, microbiome and toxin assessment) helps personalize prevention and treatment strategies.
Statins have a role for high‑risk patients but should not be reflexively prescribed to everyone with “high cholesterol”; lifestyle, nutrition, and root‑cause functional medicine can often normalize risk factors and reduce or eliminate the need for medication.

Cholesterol as one factor, not the whole cause

Dr. Mark Hyman opens by noting that cholesterol is just one factor influencing cardiovascular disease risk, despite the common belief that lowering cholesterol is the “secret” to preventing heart disease. Dr. Elizabeth Boham agrees, pointing out that around half of people in the US and Europe have “elevated” cholesterol, yet not all of them need to be on statins, because cholesterol is only one piece of a complex risk puzzle.

Limits of standard cholesterol testing

They explain that the standard lipid panel most doctors order (total cholesterol, LDL, HDL, triglycerides) is antiquated and doesn’t provide enough information to make good decisions. Hyman emphasizes that these tests tell you only the “weight” of cholesterol in the blood, not how many particles are carrying that cholesterol or how big those particles are, both of which strongly influence risk.

Dirt and dump trucks, golf balls and beach balls

Boham uses the “dirt and dump trucks” analogy: cholesterol is the dirt and lipoprotein particles are the dump trucks, and what matters is not just how much dirt you have but how many trucks and how big they are. Hyman adds the “golf balls versus beach balls” analogy to illustrate that small, dense LDL particles (golf balls) can damage arteries more than large, light, fluffy particles (beach balls) even if the total cholesterol level is the same.

Why some “high cholesterol” people are low risk

They describe patients with very high total cholesterol (around 300) and LDL (around 150) but extremely high HDL (for example, 110) and large, fluffy particles, who are lean, active, and otherwise healthy. In such cases, advanced testing may show minimal small, dense LDL and low overall particle numbers, indicating low actual risk, which is why some cardiology leaders would not put these patients on statins despite “abnormal” cholesterol.

Why “normal cholesterol” can still be dangerous

Conversely, they describe patients with total cholesterol as low as 150 who have very high particle numbers, large amounts of small, dense LDL, and a triglyceride‑to‑HDL ratio that suggests severe insulin resistance. These patients can be at high risk for heart disease even though their total cholesterol looks excellent on a standard report, which is why focusing only on total or LDL cholesterol can be misleading and dangerous.

Advanced particle testing and insulin resistance scores

Boham recommends particle size and number testing such as NMR lipoprotein profiles (LabCorp) and Cardio IQ (Quest), which can be ordered through standard labs and insurance. These tests can also provide an insulin resistance score based on lipoprotein patterns, further clarifying metabolic health and hidden cardiovascular risk beyond traditional numbers.

Insulin resistance, metabolic syndrome, and the SAD diet

The conversation turns to lifestyle drivers of dangerous lipid patterns, especially insulin resistance and metabolic syndrome, which are closely tied to the standard American diet rich in sugar, refined carbohydrates, processed foods, and excess alcohol. They note that people with metabolic syndrome typically have increased belly fat, low HDL, high triglycerides, and more small, dense LDL particles, with diet being the biggest lever to improve these patterns.

Belly fat as an inflammatory organ

Hyman and Boham explain that visceral belly fat is not inert storage but an active immune organ secreting inflammatory molecules called adipocytokines, similar to a chronic low‑grade “cytokine storm.” This inflammation contributes to oxidative stress, which damages LDL particles, turning them into oxidized (rancid) LDL that is much more likely to form unstable plaque in arteries.

Oxidative stress and oxidized LDL

They define oxidative stress as an excess of free radicals relative to antioxidant defenses, likening it to rusting metal, browning apples, or skin wrinkling from too much sun. When LDL is oxidized under conditions of poor diet and low intake of polyphenol‑rich vegetables and other antioxidants, it becomes more damaging, more prone to plaque formation, and more likely to trigger heart attacks and strokes.

Inflammation as the missing ingredient

Hyman cites studies such as the JUPITER trial showing that people with high LDL but low inflammation have lower risk than people with high inflammation and relatively normal cholesterol. The highest risk occurs when both cholesterol and inflammation are elevated, suggesting that inflammation and oxidative stress are the missing ingredients that convert cholesterol into a true threat.

The broader root‑cause lens in functional medicine

The doctors describe their functional medicine approach at The UltraWellness Center, where they assess a broad set of root causes: diet, insulin resistance, oxidative stress, microbiome imbalances, toxins (including heavy metals and air pollution), sleep apnea, stress, and more. They use specialized tests such as oxidized LDL, fasting insulin, 8‑hydroxy‑deoxyguanosine, lipid peroxides, homocysteine, and lipoprotein(a), along with microbiome and toxin assessments, to personalize prevention and treatment.

Plaque rupture and sudden heart attacks

They explain that sudden heart attacks often occur not when an artery is gradually narrowed from 50 to 90 to 100 percent, but when a relatively modest plaque (around 30 percent narrowing) becomes inflamed and ruptures. This rupture triggers a clot, abruptly blocking blood flow and causing a heart attack, which is why inflammation and plaque stability are crucial and why many patients have little warning before a major event.

The triglyceride to HDL ratio as a simple clue

Hyman highlights the triglyceride‑to‑HDL ratio as a simple, inexpensive marker of insulin resistance and heart risk that is often more predictive than LDL alone. Ratios over 2 are concerning, and in one case example they discuss a patient with a ratio around 5, indicating high risk despite only moderately elevated total cholesterol.

Case study: reversing pattern B with diet and omega‑3s

Boham presents a 45‑year‑old man with total cholesterol 225, low HDL (37), high triglycerides (185), LDL 145, and NMR showing pattern B (many small, dense LDL), all pointing to insulin resistance and high cardiovascular risk. By putting him on a low‑glycemic, low‑sugar, low‑flour diet, reducing alcohol and refined carbs, and increasing omega‑3 intake (fish oil and fatty fish like sardines), she helped him transform his pattern to safer pattern A, raise HDL, and lower triglycerides from 185 to about 120 in only three months.

How sugar, not fat, drives triglycerides

They explain that triglycerides are largely produced in the liver from excess sugar and refined starch, not from eating fat, and that removing juice, sugar, refined flour, excess fruit, and alcohol can rapidly drop triglyceride levels. Omega‑3 fats (2–4 grams per day) also lower triglycerides and raise HDL, and high‑dose fish oil is even FDA‑approved as a triglyceride‑lowering therapy, though the same effect can often be achieved with food like sardines and salmon.

Personalizing diet: when saturated fat helps or harms

Hyman shares contrasting cases showing that diet must be individualized: in one prediabetic, overweight woman with high triglycerides and low HDL, a high‑fat, high‑saturated‑fat, low‑carb diet (butter and coconut‑oil‑rich, almost ketogenic) led to dramatic weight loss and improved cholesterol. In another very fit cyclist with a genetic cholesterol issue, the same high‑fat approach worsened his lipids, and they had to reduce saturated fat and adjust the diet, illustrating how genetics and metabolism shape each person’s response.

Statins, family history, and appropriate use

They turn to statins, emphasizing that these drugs have benefits and risks and should be reserved for the right patients based on comprehensive risk, not just LDL levels. Boham looks closely at family history (early heart attacks in first‑degree relatives), smoking, weight, blood pressure, diabetes, and evidence of plaque when deciding whether a statin is warranted, while also recognizing that simple lifestyle practices like daily walking can dramatically alter genetic risk expression.

Lifestyle as powerful medicine

The doctors repeatedly show how lifestyle changes—diet, movement, weight loss, improving sleep, reducing stress, cleaning up environmental exposures, and supporting the microbiome—can normalize metabolic health and dramatically reduce heart disease risk. In one memorable case, Hyman describes a 50‑year‑old man with a prior heart attack who lost around 50 pounds, reversed prediabetes, optimized particle numbers and size, and was able to come off all heart medications, remaining heart‑attack free for twenty years.

The future of precision prevention

They foresee a future in which simple genetic tests (via cheek swab or finger‑stick blood) will help determine who does best on higher‑fat versus higher‑carbohydrate diets, and how saturated fat or other nutrients affect each person’s cholesterol channels. Until then, they use functional medicine tools, advanced lab testing, and iterative experimentation to personalize nutrition and lifestyle plans, instead of applying a one‑size‑fits‑all “low‑fat, low‑cholesterol” prescription.